Published in Cancer Weekly, August 4th, 2009
"In Hepa 1-6, L6, and 3T3-L1 cells, epigallocatechin gallate (EGCG) induced increases in AMPK alpha and the downstream target acetyl-CoA carboxylase (ACC) phosphorylation, and AMPKa activity. Analysis of the molecular specificity...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.